We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Calorie Restriction Activates Life Extending Genes

By Biotechdaily staff writers
Posted on 22 Apr 2004
Researchers studying the biochemical factors that control aging have found that calorie restriction, the consumption of fewer calories while avoiding malnutrition, causes changes that result in slowing the aging process in mice, even in older animals.

Investigators at the University of California at Riverside (USA) collaborated with colleagues from BioMarker Pharmaceutical Inc. (Campbell, CA, USA) to study the effects of calorie restriction on a population of older mice. They found that when 19-month-old mice were placed on a regimen of calorie restriction, mean time to death increased by 42% within two months. Tumors as a cause of death decreased from 80% to 67%. Genome-wide microarray analysis of hepatic RNA from old control mice switched to calorie restriction diets for two, four, and eight weeks showed a rapid and progressive shift toward the gene expression profile produced by long-term calorie restriction.

Shifting from long-term calorie restriction to a control diet, which returned the animals to the control rate of aging, reversed 90% of the gene expression effects of long-term calorie restriction within eight weeks. These findings were published in the March 25, 2004, online edition of the Proceedings of the [U.S] National Academy of Sciences.

"The beneficial effects of calorie restriction have been known for some time, but only when animals are started on the diet early in life. This is the first demonstration that these effects can be obtained even when calorie restriction is started late in life,” explained Dr. Joseph Dhahbi, research director at BioMarker Pharmaceutical.




Related Links:
University of California, Riverside
BioMarker Pharmaceutical Inc.

New
Gold Member
Aspiration System
VACUSAFE
New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
New
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]

Latest BioResearch News

Study Identifies Protein Changes Driving Immunotherapy Resistance in Multiple Myeloma
22 Apr 2004  |   BioResearch

Genetic Analysis Identifies BRCA-Linked Risks Across Multiple Cancers
22 Apr 2004  |   BioResearch

Study Identifies Hidden B-Cell Mutations in Autoimmune Disease
22 Apr 2004  |   BioResearch